MCRBNasdaqPharmaceutical Preparations

Seres Therapeutics, Inc. (MCRB) earnings date, market-implied expected move, and options open interest by expiry

2.02

−0.07 · −3.13%

post 2.06 +1.75%

After hours16:25 ETdelayed

Open2.12Volume94,587Mkt cap$21.3M

Day2.02 – 2.1725%52-wk1.68 – 29.981%

MCRB

Seres Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Mar 8

before open · in 122 days

est.Q4 FY26

Calendar

Next report

Last report

+6.63%

vs ±32.5% implied · ×0.20

shaded = implied · ▲▼ = realized

Nov 4 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

−2.88%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

34 managers

Top fund weight

0.00%

MCRB weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Seres Therapeutics (MCRB) is expected to report on Mar 8 before open (estimated date).

Implied vs realized

2 reports

—≥ implied

Q2 FY26Aug 5 '26confirmed±41.0%▼−4.67%×0.11

Q3 FY26Nov 4 '26confirmed±32.5%▲+6.63%×0.20

quarterimplied−45%0+45%realized×

Q3 FY26±32.5%▲+6.63%×0.20

Q2 FY26±41.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Nov 3 close

0.31OI · 2 expiries · Nov 3 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

3090%Nov 2014d989+118%

924−1%Jan 1570d0.313,004+3%0.31

ExpiryPutsCallsP/C

Nov 2014d3090%989+118%0.31

Jan 1570d924−1%3,004+3%0.31

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−2746.37%as filednet margin · revenue −19.43% QoQ · +68.95% YoY

Revenue$593,000−19.43%

Gross profit$593,000100.00%−19.43%

Operating income−$16M−2723.78%+24.07%

Pre-tax income−$16M−455.51%

Net income−$16M−2746.37%−455.51%

Cost of revenue$0—

Operating expenses$17M−23.92%

Other expense−$134,000−100.52%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:15 ET

Intraday

Event sensitivity

FOMC ×1.00· ±4.7% vs ±4.7% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±4.7%10 of 24×1.00

GDPgross domestic product±3.8%12 of 20×0.82

PCEpersonal income & outlays±3.1%8 of 20×0.66

PPIproducer prices±2.6%4 of 11×0.57

CPIconsumer prices±2.4%5 of 11×0.52

NFPjobs report±2.1%5 of 11×0.45

CPROFcorporate profits±1.9%6 of 12×0.40

Bar = avg |move| to ±5% · tick = ±4.7% avg day · ×base = |move| ÷ ±4.7% · min 6 releases

Earnings history

EPS -1.63 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 4 '26 · confirmed	-1.63	—
Q2 FY26	Aug 5 '26 · confirmed	0.47	—
Q1 FY26	—	-2.08	—
Q3 FY25	—	0.94	—

Methodology

ties · implied moves · holdersMethod